Prognostic Impact of Prolonged Cross-Clamp Time in Coronary Artery Bypass Grafting

Vito G Ruggieri1, Karl Bounader1, Jean Philippe Verhoye1

  • 1Division of Cardiothoracic and Vascular Surgery, Pontchaillou University Hospital, Rennes, France.

Heart, Lung & Circulation
|December 26, 2017
PubMed

Insights

Prolonged cross-clamp time (XCT) during isolated coronary artery bypass grafting (CABG) is linked to increased early mortality. Strategies to minimize XCT are crucial for improving patient outcomes after CABG surgery.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Surgery Outcomes
  • Surgical Efficiency

Background:

  • The prognostic significance of cross-clamp time (XCT) in isolated coronary artery bypass grafting (CABG) remains under-investigated.
  • Optimizing surgical times is critical for patient safety and recovery.

Purpose of the Study:

  • To investigate the association between cross-clamp time (XCT) and early outcomes in patients undergoing isolated on-pump CABG.
  • To identify specific XCT thresholds associated with increased mortality and adverse events.

Main Methods:

  • Analysis of 2957 patients from the prospective multicentre E-CABG study undergoing on-pump isolated CABG.
  • Multivariate analysis and propensity score matching were used to assess the impact of XCT on 30-day mortality and major adverse events.

Main Results:

  • Mean XCT was 58±25 minutes, with 38.3% of patients exceeding 60 minutes.
  • XCT was an independent predictor of 30-day mortality (OR 1.027).
  • XCT >75 minutes was associated with significantly higher adjusted risk of 30-day mortality (OR 3.479) and increased rates of major adverse events.

Conclusions:

  • A significant proportion of isolated CABG procedures involve prolonged XCT.
  • Prolonged XCT is a determinant of poor early outcomes, including increased mortality and complications.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
553
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
430
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
736
Crossing Over01:34

Crossing Over

Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process...
172.4K